Literature DB >> 7535867

Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.

J D Lippolis1, L M Mylin, D T Simmons, S S Tevethia.   

Abstract

Simian virus 40 tumor (T) antigen contains three H-2Db-and one H-2Kb-restricted cytotoxic T lymphocyte (CTL) epitopes (sites). Two of the H-2Db-restricted CTL epitopes, I and II/III, are separated by 7 amino acids in the amino-terminal one third of T antigen. In this study, we determine if the amino acids separating these two H-2Db-restricted CTL epitopes are dispensable for efficient processing and presentation. In addition, the importance of amino acid residues lying within and flanking the H-2Db-restricted epitopes I and II/III for efficient processing, presentation, and recognition by site-specific CTL clones was determined by using T-antigen mutants containing single-amino-acid substitutions between residues 200 and 239. Using synthetic peptides in CTL lysis and major histocompatibility complex class I stabilization assays, CTL recognition site I has been redefined to include residues 206 to 215. Substitutions in amino acids flanking either site I or site II/III did not affect recognition by any of the T-antigen-specific CTL clones. Additionally, the removal of the 7 residues separating site I and site II/III did not affect CTL recognition, thus demonstrating that these two epitopes when arranged in tandem in the native T antigen can be efficiently processed and presented to CTL clones. Differences in fine specificities of two CTL clones which recognize the same epitope (Y-1 and K-11 for site I and Y-2 and Y-3 for site II/III) have been used in conjunction with synthetic peptide variants to assign roles for residues within epitopes I and II/III with respect to TCR recognition and/or peptide-major histocompatibility complex association.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535867      PMCID: PMC189015     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Site-directed mutations in the VDJ junctional region of a T cell receptor beta chain cause changes in antigenic peptide recognition.

Authors:  I Engel; S M Hedrick
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

2.  In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.

Authors:  Y Tanaka; S S Tevethia
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

3.  Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein.

Authors:  E Joly; M Salvato; J L Whitton; M B Oldstone
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Selection of amino acid sequences in the beta chain of the T cell antigen receptor.

Authors:  S M Hedrick; I Engel; D L McElligott; P J Fink; M L Hsu; D Hansburg; L A Matis
Journal:  Science       Date:  1988-03-25       Impact factor: 47.728

5.  Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones.

Authors:  A E Campbell; F L Foley; S S Tevethia
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

Authors:  H Acha-Orbea; D J Mitchell; L Timmermann; D C Wraith; G S Tausch; M K Waldor; S S Zamvil; H O McDevitt; L Steinman
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

7.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

Authors:  J L Urban; V Kumar; D H Kono; C Gomez; S J Horvath; J Clayton; D G Ando; E E Sercarz; L Hood
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

8.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

Authors:  A Townsend; J Bastin; K Gould; G Brownlee; M Andrew; B Coupar; D Boyle; S Chan; G Smith
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

9.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.

Authors:  M B Oldstone; J L Whitton; H Lewicki; A Tishon
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin.

Authors:  T A Potter; C Boyer; A M Verhulst; P Golstein; T V Rajan
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  9 in total

1.  Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones.

Authors:  Lawrence M Mylin; Todd D Schell; Melanie Epler; Caroline Kusuma; David Assis; Chelsea Matsko; Alexandra Smith; April Allebach; Satvir S Tevethia
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

2.  Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.

Authors:  T D Schell; L M Mylin; I Georgoff; A K Teresky; A J Levine; S S Tevethia
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.

Authors:  T M Fu; L M Mylin; T D Schell; I Bacik; G Russ; J W Yewdell; J R Bennink; S S Tevethia
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.

Authors:  L M Mylin; T D Schell; D Roberts; M Epler; A Boesteanu; E J Collins; J A Frelinger; S Joyce; S S Tevethia
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors:  V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.

Authors:  L M Mylin; R H Bonneau; J D Lippolis; S S Tevethia
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Combined anti-CD40 conditioning and well-timed immunization prolongs CD8+ T cell accumulation and control of established brain tumors.

Authors:  Christina M Ryan; Kevin Staveley-O'Carroll; Todd D Schell
Journal:  J Immunother       Date:  2008 Nov-Dec       Impact factor: 4.456

8.  In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.

Authors:  Todd D Schell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.

Authors:  Alan M Watson; L K Metthew Lam; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2016-07-27       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.